BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $667,000 | -9.4% | 64,586 | 0.0% | 0.04% | -15.2% |
| Q3 2015 | $736,000 | +243.9% | 64,586 | +266.5% | 0.05% | +283.3% |
| Q4 2014 | $214,000 | -39.2% | 17,621 | -51.0% | 0.01% | -40.0% |
| Q3 2014 | $352,000 | -37.8% | 35,944 | -32.8% | 0.02% | -37.5% |
| Q1 2014 | $566,000 | -22.7% | 53,520 | -44.5% | 0.03% | -15.8% |
| Q4 2013 | $732,000 | +11.6% | 96,346 | +6.9% | 0.04% | +2.7% |
| Q3 2013 | $656,000 | – | 90,127 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |